Archive · 1 Sep 2025
Alkem Labs and Dr. Lal PathLabs Show Buy Signals
The stock market is showing that two healthcare companies, Alkem Laboratories and Dr. Lal PathLabs, might be good investments.
These companies' stocks seem to be doing better than others in the pharma sector.
The market is looking at the stock charts and seeing signals that these stocks are likely to go up in value.
Both companies had a period of decline, but now they are showing signs of recovery and growth.
Based on their performance and the patterns on their charts, experts believe that they could be a good choice for investors looking to make money in the stock market.
Alkem Laboratories and Dr. Lal PathLabs show bullish patterns.
The Nifty 50 grew 3.5% between April and August 2025.
The Indian Pharma Index grew by 2.5% during the same period.
Alkem Lab has broken out from the double bottom pattern and falling trendline.
Dr. Lal PathLabs shares have strongly appreciated from INR 2,300 to INR 3,500, an increase of 52%.
- Who
- Alkem Laboratories and Dr. Lal PathLabs
- What
- Show promising growth potential based on technical indicators, suggesting potential for investors.
- When
- Between April and August 2025
- Where
- Indian Financial Markets
- Why
- Due to bullish patterns and strong support shown on price charts.
- Alkem Labs Decline
- 30% from peak in Sept 2024
- Dr. Lal PathLabs Decline
- From INR 3,600 to INR 2,300 (Oct 2024 - Feb 2025)
- Dr. Lal PathLabs Increase
- 52% between Feb and August 2025
- Nifty 50 Growth
- 3.5% (April - August 2025)
- Indian Pharma Index Growth
- 2.5% (April - August 2025)